182 related articles for article (PubMed ID: 15083198)
1. Alpha-tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells.
Tomasetti M; Rippo MR; Alleva R; Moretti S; Andera L; Neuzil J; Procopio A
Br J Cancer; 2004 Apr; 90(8):1644-53. PubMed ID: 15083198
[TBL] [Abstract][Full Text] [Related]
2. Role of thioredoxin-1 in apoptosis induction by alpha-tocopheryl succinate and TNF-related apoptosis-inducing ligand in mesothelioma cells.
Freeman RE; Neuzil J
FEBS Lett; 2006 May; 580(11):2671-6. PubMed ID: 16647070
[TBL] [Abstract][Full Text] [Related]
3. Alpha-tocopheryl succinate induces DR4 and DR5 expression by a p53-dependent route: implication for sensitisation of resistant cancer cells to TRAIL apoptosis.
Tomasetti M; Andera L; Alleva R; Borghi B; Neuzil J; Procopio A
FEBS Lett; 2006 Apr; 580(8):1925-31. PubMed ID: 16529749
[TBL] [Abstract][Full Text] [Related]
4. Alpha-tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-kappaB activation.
Dalen H; Neuzil J
Br J Cancer; 2003 Jan; 88(1):153-8. PubMed ID: 12556975
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.
Nimmanapalli R; Perkins CL; Orlando M; O'Bryan E; Nguyen D; Bhalla KN
Cancer Res; 2001 Jan; 61(2):759-63. PubMed ID: 11212279
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo.
Weber T; Lu M; Andera L; Lahm H; Gellert N; Fariss MW; Korinek V; Sattler W; Ucker DS; Terman A; Schröder A; Erl W; Brunk UT; Coffey RJ; Weber C; Neuzil J
Clin Cancer Res; 2002 Mar; 8(3):863-9. PubMed ID: 11895920
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.
Keane MM; Ettenberg SA; Nau MM; Russell EK; Lipkowitz S
Cancer Res; 1999 Feb; 59(3):734-41. PubMed ID: 9973225
[TBL] [Abstract][Full Text] [Related]
8. Tocopherol-associated protein-1 accelerates apoptosis induced by alpha-tocopheryl succinate in mesothelioma cells.
Neuzil J; Dong LF; Wang XF; Zingg JM
Biochem Biophys Res Commun; 2006 May; 343(4):1113-7. PubMed ID: 16579965
[TBL] [Abstract][Full Text] [Related]
9. Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.
Johnsen JI; Pettersen I; Ponthan F; Sveinbjørnsson B; Flaegstad T; Kogner P
Int J Oncol; 2004 Dec; 25(6):1849-57. PubMed ID: 15547726
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria play a central role in apoptosis induced by alpha-tocopheryl succinate, an agent with antineoplastic activity: comparison with receptor-mediated pro-apoptotic signaling.
Weber T; Dalen H; Andera L; Nègre-Salvayre A; Augé N; Sticha M; Lloret A; Terman A; Witting PK; Higuchi M; Plasilova M; Zivny J; Gellert N; Weber C; Neuzil J
Biochemistry; 2003 Apr; 42(14):4277-91. PubMed ID: 12680782
[TBL] [Abstract][Full Text] [Related]
11. The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand.
Ozoren N; Kim K; Burns TF; Dicker DT; Moscioni AD; El-Deiry WS
Cancer Res; 2000 Nov; 60(22):6259-65. PubMed ID: 11103780
[TBL] [Abstract][Full Text] [Related]
12. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
[TBL] [Abstract][Full Text] [Related]
13. TNF-related apoptosis-inducing ligand-induced apoptosis of melanoma is associated with changes in mitochondrial membrane potential and perinuclear clustering of mitochondria.
Thomas WD; Zhang XD; Franco AV; Nguyen T; Hersey P
J Immunol; 2000 Nov; 165(10):5612-20. PubMed ID: 11067917
[TBL] [Abstract][Full Text] [Related]
14. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
Ng CP; Zisman A; Bonavida B
Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis is inhibited by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human colon cancer cells.
Sinicrope FA; Penington RC; Tang XM
Clin Cancer Res; 2004 Dec; 10(24):8284-92. PubMed ID: 15623604
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines.
Liu W; Bodle E; Chen JY; Gao M; Rosen GD; Broaddus VC
Am J Respir Cell Mol Biol; 2001 Jul; 25(1):111-8. PubMed ID: 11472983
[TBL] [Abstract][Full Text] [Related]
17. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.
Seol DW; Li J; Seol MH; Park SY; Talanian RV; Billiar TR
Cancer Res; 2001 Feb; 61(3):1138-43. PubMed ID: 11221844
[TBL] [Abstract][Full Text] [Related]
18. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
19. Alpha-tocopheryl succinate inhibits malignant mesothelioma by disrupting the fibroblast growth factor autocrine loop: mechanism and the role of oxidative stress.
Stapelberg M; Gellert N; Swettenham E; Tomasetti M; Witting PK; Procopio A; Neuzil J
J Biol Chem; 2005 Jul; 280(27):25369-76. PubMed ID: 15878867
[TBL] [Abstract][Full Text] [Related]
20. TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer.
Odoux C; Albers A; Amoscato AA; Lotze MT; Wong MK
Int J Cancer; 2002 Feb; 97(4):458-65. PubMed ID: 11802207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
